Is YDES research on Rallies investment advice?

No. Rallies provides research, data, and educational context for YDES. It does not provide personalized investment advice.

YDES (YD Bio Limited Ordinary Shares) Stock Analysis - Financials

YD Bio Limited Ordinary Shares (YDES) is a publicly traded the market company. As of July 28, 2026, YDES trades at $2.21 with a market cap of $158.66M and a P/E ratio of 0.00. YDES moved +0.00% today. Year to date, YDES is -81.21%; over the trailing twelve months it is flat. Its 52-week range spans $1.70 to $25.00. Rallies surfaces YDES's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are YDES's key financials?

YDES financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. YDES recently traded at $2.21. Market cap is $158.66M. P/E ratio is 0.00. Revenue is $0.

YDES Key Metrics

Key financial metrics for YDES
Metric	Value
Price	$2.21
Market Cap	$158.66M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$25.00
52-Week Low	$1.70
Volume	18.89K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

YDES Analyst Consensus

YDES analyst coverage data. Average price target: $0.00.

Common questions about YDES

What are YDES's key financials?: YDES financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. YDES recently traded at $2.21. Market cap is $158.66M. P/E ratio is 0.00. Revenue is $0.
Is YDES research on Rallies investment advice?: No. Rallies provides research, data, and educational context for YDES. It does not provide personalized investment advice.